Effects of Sex and Neutering on mRNA Transcription for M1 and M2 Receptors in the Canine Urinary Bladder
World Small Animal Veterinary Association World Congress Proceedings, 2007
Victoria Coit; Christine Whitelaw; Fiona Dowell; Neil Evans
Glasgow University Veterinary School

Acquired urinary incontinence in the bitch (AUI) is currently reported to affect 20% of neutered bitches and <1% of intact bitches and males; however the full aetiology of the condition remains unknown.

Our previous in vitro study demonstrated that neutering is associated with a decrease in response to muscarinic stimulation of the detrusor muscle in the canine, independent of gender. The aim of this study was to investigate whether neutering altered the expression of mRNA for M1 and M2 receptors in the bladder wall.

Sections of bladder wall were dissected post mortem from entire and neutered male and female dogs (ME, MN, FE, FN respectively) with informed owner consent. RNA was extracted; reverse transcribed and M1, M2 mRNA expression quantified by rtPCR (relative to β-actin).

Table1. Relative expression levels of mRNA, presented as mean ± s.e. mean where n = number of dogs.


ME (n=15)

MN (n=10)

FE (n=12)

FN (n=7)











Analysis of variance (Bonferroni post-test) show M1 and M2 mRNA expression was significantly (p<0.05) decreased in male compared to female animals, and significantly increased in neutered compared to entire animals (M1 both sexes, M2 males only).

These results demonstrate that neutering a dog is associated with increased M1 and M2 mRNA expression in the bladder. These dynamic changes indicate differential mechanisms through which neutering and gender may influence bladder responsiveness and thus AUI.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Victoria Coit
Glasgow University Veterinary School
United Kingdom

MAIN : Abstracts - Oral : Effects of Sex & Neutering
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.


777 W. Covell Blvd., Davis, CA 95616



  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357